Literature DB >> 23467223

Biotech comes to its 'antisenses' after hard-won drug approval.

Kevin Jiang.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23467223     DOI： 10.1038/nm0313-252

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  2 in total

1.  Call in the backup.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2012-11       Impact factor: 53.440

2.  Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.

Authors:  Frederick J Raal; Raul D Santos; Dirk J Blom; A David Marais; Min-Ji Charng; William C Cromwell; Robin H Lachmann; Daniel Gaudet; Ju L Tan; Scott Chasan-Taber; Diane L Tribble; Joann D Flaim; Stanley T Crooke
Journal:  Lancet       Date:  2010-03-20       Impact factor: 79.321
  2 in total
  9 in total

Review 1.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development.

Authors:  Hui Ling; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

2.  Synthesis of dinucleoside acylphosphonites by phosphonodiamidite chemistry and investigation of phosphorus epimerization.

Authors:  William H Hersh
Journal:  Beilstein J Org Chem       Date:  2015-01-30       Impact factor: 2.883

Review 3.  Antisense therapy in neurology.

Authors:  Joshua J A Lee; Toshifumi Yokota
Journal:  J Pers Med       Date:  2013-08-02

4.  Peptide Nucleic Acid Knockdown and Intra-host Cell Complementation of Ehrlichia Type IV Secretion System Effector.

Authors:  Pratibha Sharma; Omid Teymournejad; Yasuko Rikihisa
Journal:  Front Cell Infect Microbiol       Date:  2017-06-07       Impact factor: 5.293

Review 5.  Non-coding RNAs in cancer diagnosis and therapy.

Authors:  Mahmood Rasool; Arif Malik; Sara Zahid; Muhammad Abdul Basit Ashraf; Mahmood Husain Qazi; Muhammad Asif; Ahmad Zaheer; Muhammad Arshad; Amir Raza; Mohammad Sarwar Jamal
Journal:  Noncoding RNA Res       Date:  2016-11-11

Review 6.  Emerging Contribution of PancRNAs in Cancer.

Authors:  Neri Mercatelli; Ramona Palombo; Maria Paola Paronetto
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

Review 7.  Merkel Cell Carcinoma: Epidemiology, Target, and Therapy.

Authors:  Mathew P Hughes; Matthew E Hardee; Lynn A Cornelius; Laura F Hutchins; Jurgen C Becker; Ling Gao
Journal:  Curr Dermatol Rep       Date:  2014-01-22

8.  Chimeric Antisense Oligonucleotide Conjugated to α-Tocopherol.

Authors:  Tomoko Nishina; Junna Numata; Kazutaka Nishina; Kie Yoshida-Tanaka; Keiko Nitta; Wenying Piao; Rintaro Iwata; Shingo Ito; Hiroya Kuwahara; Takeshi Wada; Hidehiro Mizusawa; Takanori Yokota
Journal:  Mol Ther Nucleic Acids       Date:  2015-01-13       Impact factor: 10.183

9.  DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing.

Authors:  Kazutaka Nishina; Wenying Piao; Kie Yoshida-Tanaka; Yumiko Sujino; Tomoko Nishina; Tsuyoshi Yamamoto; Keiko Nitta; Kotaro Yoshioka; Hiroya Kuwahara; Hidenori Yasuhara; Takeshi Baba; Fumiko Ono; Kanjiro Miyata; Koichi Miyake; Punit P Seth; Audrey Low; Masayuki Yoshida; C Frank Bennett; Kazunori Kataoka; Hidehiro Mizusawa; Satoshi Obika; Takanori Yokota
Journal:  Nat Commun       Date:  2015-08-10       Impact factor: 14.919
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.